분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-02-01 15:17:34 , Hit : 761
 CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect

GEN News
Jan 27, 2016
  
Skin cells from a patient with X-linked retinitis pigmentosa were transformed into induced pluripotent stem cells, and the blindness-causing point mutation in the RPGR gene was corrected using CRISPR/Cas9. [Vinit Mahajan, University of Iowa Health Care]  

Marking yet another CRISPR-related first, scientists have replaced a defective gene associated with a sensory disease in stem cells that were derived from a patient’s tissue. The disease, retinitis pigmentosa (RP), is an inherited condition that degrades the retina and leads to blindness. A patient with the disease supplied a skin sample that was used to generate the stem cells, which were manipulated by means of the CRISPR/Cas9 gene-editing system.

CRISPR/Cas9, which zeroed in on a single disease-causing mutation in the RGPR gene, was able to make the necessary correction in 13% of the stem cells. This correction rate, according to the Columbia University and University of Iowa scientists who announced the results, is indicative of a practical approach—albeit one that still needs work. The Columbia/Iowa team added that they are working to show that their technique does not introduce any unintended genetic modifications in human cells, and that the corrected cells are safe for transplantation.

While the scientists freely acknowledge that their technique needs additional development before any cures are possible, they basked in the success of having accomplished a difficult genetic fix. The RGPR mutation that needed to be repaired sits in a highly repetitive sequence of the gene where it can be tricky to discriminate one region from another. In fact, it was not clear that CRISPR/Cas9 would be able to home in on and correct the point mutation.

The scientists described their work January 27 in the journal Scientific Reports in an article entitled “Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.”

“Fibroblasts cultured from a skin-punch biopsy of an XLRP patient were transduced to produce [induced pluripotent stem cells (iPSCs)] carrying the patient’s c.3070G > T mutation,” the authors wrote. “The iPSCs were transduced with CRISPR guide RNAs, Cas9 endonuclease, and a donor homology template. Despite the gene’s repetitive and GC-rich sequences, 13% of RPGR gene copies showed mutation correction and conversion to the wild-type allele.”

The authors asserted that theirs was the first report of CRISPR/Cas9 being used to correct a pathogenic mutation in iPSCs derived from a patient with photoreceptor degeneration. This proof-of-concept finding, they added, supports the development of personalized iPSC-based transplantation therapies for retinal disease.

The authors also emphasized that because the corrections are made in cells derived from the patient's own tissue, doctors can retransplant the cells with fewer fears of rejection by the immune system. Previous clinical trials have shown that generating retinal cells from embryonic stem cells and using them for transplantation is a safe and potentially effective procedure.

Recently, another group has used CRISPR to ablate a disease-causing mutation in rats with retinitis pigmentosa. Going forward, the first clinical use of CRISPR could be for treating an eye disease because compared to other body parts, the eye is easy to access for surgery, readily accepts new tissue, and can be noninvasively monitored.







1107   Tunable Form of CRISPR Is an Efficient Regulator of Stem Cell Expression  이성욱 2016/03/14 700
1106   NIH 연구진들은 5가지 종류의 암에서 공유되는 충격적인 게놈 상의 특징을 확인  이성욱 2016/03/09 828
1105   특허전쟁: 미국 특허청, CRISPR의 특허권 중재 시작  이성욱 2016/03/08 1046
1104   거대 바이러스에게서도 발견된 CRISPR 유사 시스템  이성욱 2016/03/02 1122
1103   MIT 선정 2015년 주목받은 Biomedicine 뉴스  이성욱 2016/02/03 887
1102   CRISPR Editing of Human Embryos Approved in the U.K.  이성욱 2016/02/02 806
  CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect  이성욱 2016/02/01 761
1100   유전자치료제 연구개발 및 규제 동향 2015-식품의약품안전처  이성욱 2016/01/20 1063
1099   융합연구리뷰 | Convergence Research Review  이성욱 2016/01/08 1055
1098   유전자 편집 기술로 작물 유전자 편집  이성욱 2015/12/05 1163
1097   장 펑, 좀 더 정확한 유전자가위 개발  이성욱 2015/12/05 916
1096   세계 20여 개국 과학자들, 유전자편집 정상회담 개최  이성욱 2015/12/05 1077
1095   유전자 편집이란 무엇인가? 누구나 알아야 할 7가지 사실  이성욱 2015/12/05 1128
1094   목숨을 위협하는 바이러스 감염에 대한 유망 치료법  이성욱 2015/11/26 1145
1093   C형 간염에 보다 효과적인 새로운 복합제  이성욱 2015/11/24 975
1092   유전자 드라이브의 안전성 업그레이드  이성욱 2015/11/19 1131
1091   인간에게 꼭 필요한 유전자는 3,230개  이성욱 2015/11/18 875
1090   유전자편집치료에 희망을 준 백혈병치료  이성욱 2015/11/11 1101
1089   [바이오토픽] C형간염을 3주 만에 치료하는 DAA 3제요법  이성욱 2015/11/02 1067
1088   미 FDA, 암 잡는 바이러스 승인  이성욱 2015/10/30 1137

[1][2][3][4][5][6][7][8] 9 [10]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN